Pharmaceutical
Welcome to the newest addition to CHC's practice areas

Creative Healthcare is pleased to introduce research and resources in its new practice area, reflecting a growing convergence between technology and drug discovery. Please visit often to find new articles, programs and services that profile our growing presence in the pharmaceutical industry.

• Pharma embraces Six Sigma & Lean. Six Sigma and Lean have made their mark on all industries in the manufacturing and service sector. Pharma may very well be the final frontier; as that industry comes under increased pressure to become more efficient.
• E-rasing obstacles to effective clinical trials is made possible by new technology tools and web-based resources. CHC managing partner Ian R. Lazarus provides this review of current technology options in the September 2001 issue of Pharmaceutical Executive.
• "Plastic or Paper?" Clinical Research Organizations still operate in a paper-based environment, but this will change as the industry comes under increasing pressure to support the necessary growth trajectories of their pharma clients. More on this in the July 2001 issue of Pharmaceutical Executive.
• Doing well by doing good read how American and European pharmaceutical companies are working to improve the quality of global health in this classic cover story from Managed Healthcare.
• Creating more effective care "down under" The Australian healthcare system has given rise to a series of innovative programs oriented around disease and behavioral management. Read about CHC's partner High Performance Healthcare and their efforts to marry technology and clinical practice in disease management.
• For a more general international perspective on issues facing multi-national suppliers, visit CHC's classic piece on "Products and Services on an International Scale" cover story for Managed Healthcare in June 1999.

Introducing CHC Programs and Services:

Creative Healthcare's most impactful program is the least creative of all. Read how "Six Sigma" data-driven analysis is creating the disruptive process that will make revolutionary changes in healthcare delivery. Is there a place for Six Sigma in drug discovery? Read about it

For a complete review of CHC consulting services, go to Creative Healthcare Consulting